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Abstract
Rosetting remains the dominant malaria parasite adhesion phenotype associated with severe disease and pathogenicity in
Africa. The formation of rosettes, whereby a Plasmodium falciparum infected erythrocyte (IE) adheres to two or more non-
IEs, is thought to facilitate the occlusion of microvascular blood vessels by adhering to host endothelial cells and other
bound IEs. Current methods of determining the rosette-disrupting capabilities of antibodies/drugs have focused on static
assays. As IEs in vivo are exposed to shear stresses within the microvasculature, the effect of flow conditions on rosetting
requires further examination. This study establishes a new rosetting flow assay using a closed perfusion system together
with inverted fluorescence microscopy and image analysis, and confirms previous reports that rosettes exist under shear
stresses equivalent to those present in the microvasculature (0.5–1.0 dyn/cm2). Furthermore, we tested the effectiveness of
rosette-disrupting PfEMP1 antibodies, heparin and fucoidan over a range of concentrations on two P. falciparum strains, and
found no statistically significant differences between the results of static and flow assays. The new flow assay is a valuable
addition to the tools available to study rosetting. However, the static assay has good predictive value and remains useful as
the standard screening test for rosette-disrupting interventions.
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Introduction
Plasmodium falciparum is the most pathogenic of the Plasmodium
species causing human malaria. Parasite survival in the human
host is enhanced by its ability to adhere to various receptors
expressed on endothelial cells, leading to sequestration of infected
erythrocytes (IEs) in the microvasculature, allowing the parasite to
avoid splenic clearance [1]. However, the presence of sequestered
IEs in the microvasculature obstructs blood flow and can lead to
hypoxia and metabolic acidosis, contributing to the patho-
physiology of life-threatening malaria [2,3]. Obstruction of small
blood vessels by sequestrated IEs is further enhanced by the
formation of rosettes [4], a mechanism whereby one IE binds two
or more non-IE, leading to larger aggregates of cells, further
compounding the risk of ischemic damage [5]. As a result,
rosetting is the dominant parasite adhesion phenotype associated
with severe malaria and pathogenicity in Africa [6,7,8]. Human
erythrocyte polymorphisms that reduce the ability of P. falciparum
to form rosettes, such as blood group O [9] and Complement
Receptor One deficiency [10], confer significant protection against
life-threatening malaria [10,11].
Given the ability of rosetting IEs to occlude microvessels and
restrict blood flow, the search for anti-rosetting agents to reverse
adhesion and unblock the microvasculature could lead to new
adjunctive treatments for severe malaria [12]. In vitro studies have
identified sulphated glycoconjugate compounds such as heparin,
fucoidan and curdlan sulphate as being effective at disrupting
rosettes [13,14,15,16]. Some of these sulphated polysaccharides
not only disrupt rosetting, but also inhibit adhesion of IEs to host
endothelial and placental receptors such as CSA and CD36
[17,18,19,20]. However, these compounds suffer from disadvan-
tages making them unsuitable for widespread clinical use, such as
limited strain-specific activity (eg heparin and heparin-derivatives)
[13], or anti-coagulant side effects (eg. curdlan sulfate) [16].
Therefore, although these compounds may have some potential as
adjunctive therapies, the search for safe, effective, broad-spectrum
anti-rosetting agents continues.
Recent advances in understanding the molecular mechanisms of
rosetting may help in the rational development of new therapies.
Rosetting is mediated by parasite molecules on the surface of IEs
binding to receptors on non-IEs. The parasite adhesion molecules
are specific members of the Plasmodium falciparum erythrocyte
membrane protein 1 (PfEMP1) family, the major erythrocyte
surface antigen expressed by the parasite [10]. PfEMP1 variants
are high molecular weight (200–350 kDa) proteins containing
multiple cysteine-rich extra-cellular domains, termed Duffy-
Binding Like (DBL) domains [21]. Recent investigations have
identified the N-terminal ‘‘NTS-DBLa’’ region of rosette-mediat-
ing PfEMP1 variants as the erythrocyte binding domain
[10,22,23,24]. Polyclonal antibodies generated against NTS-
DBLa are able to inhibit rosette formation, and also disrupt pre-
existing rosettes [25,26]. More detailed work to localize binding
sites within NTS-DBLa may lead to the development of novel
rosette-disrupting therapeutics [27,28].
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Current in vitro assays for assessing the effect of anti-rosetting
agents are carried out under static conditions. Drugs or antibodies
are added to the rosetting parasite culture suspension in eppendorf
tubes or 96 well plates, and after a short incubation, a wet
preparation is made and viewed by microscopy. The percentage of
mature IEs forming rosettes is counted to give the rosette
frequency in the presence or absence of drug/antibody. In vivo,
the environment is vastly different. The IEs are subjected to
continuous flow of the vascular system, with shear stresses ranging
from 0.5–5.0 dyn/cm2 within the microvasculature, to .10 dyn/
cm2 on the arterial side of the circulation [29]. The rheological
properties of rosettes have been examined previously using a
variety of techniques including perfusion of ex vivo rat microvas-
culature [5], micropipette manipulation and use of a cone-plate
viscometer [30,31] and use of a Laser-Assisted Optical Rotational
Cell Analyser (LORCA) [32]. Using these techniques it has been
shown that rosettes can withstand shear forces equivalent to those
found in the microvasculature [5,30,31,32]. These techniques
could be adapted for investigation of the effect of rosette-disrupting
agents under shear stress. However, they suffer from various
disadvantages, including the requirement to add non-physiological
colloidal compounds to increase viscosity that may affect rosette
strength [32], and time delays between applying shear stress and
rosette assessment by microscopy.
We therefore set out to develop a flow-based rosetting assay in
which it would be possible to test the effect of anti-rosetting agents
under shear stresses similar to those experienced by IEs in the
microvasculature in vivo [29,33]. Using the new assay we tested
antibodies against the NTS-DBLa region of PfEMP1 and
sulphated glycoconjugates (heparin and fucoidan) against two P.
falciparum rosetting strains, to determine if anti-rosetting agents
show similar rosette disruption activity under physiologically
relevant flow conditions compared to those measured in static
assays. We successfully established the rosetting flow assay, and
were able to quantify the effect of rosette-disrupting agents under
shear stresses equivalent to those found in vivo.
Materials and Methods
Parasite Strains
Two well-characterized laboratory rosetting strains IT/R29
[10,25] and TM284R+ [24,34] were used. These two strains have
distinct rosetting phenotypes, with TM284R+ showing IgM-
positive rosetting (indicating that the rosetting IEs bind the Fc
region of non-immune IgM antibodies so that their surface
becomes coated with IgM from human plasma) [35], whereas IT/
R29 is an IgM-negative rosetting strain [36]. The IgM-positive
rosetting phenotype is most closely linked to severe malaria in
African children [36]. For both strains, we have previously
identified the PfEMP1 variant that mediates rosetting, and raised
potent rosette-disrupting antibodies against the NTS-DBLa region
of PfEMP1 [10,24,25]. In addition, the sensitivity of each strain to
sulphated glycoconjugates has also been described, with IT/R29
rosettes being disrupted by both heparin and fucoidan [15],
whereas TM284R+ rosettes are not disrupted by heparin and only
partially disrupted by fucoidan [16].
Parasite Culture
Parasite cultures were grown in O+ erythrocytes (Scottish
National Blood Transfusion Service) in parasite culture medium,
comprising RPMI 1640 medium (Invitrogen) supplemented with
5% pooled human serum (Scottish National Blood Transfusion
Service), 2 mM L-glutamine (Invitrogen), 25 mM HEPES
(Lonza), 20 mM glucose (Sigma), 25 mg/mL gentamicin gulphate
(Lonza) and 0.25% Albumax II (Gibco). The pH was adjusted to
7.2–7.4 with the addition of NaOH (Sigma) and flasks were kept a
constant temperature of 37uC and gassed with 1% O2/3% CO2/
96% N2. Parasite maturity and parasitaemia were assessed by
microscopy of fixed thin blood smears stained with 10% Giemsa.
All cultures used were free from mycoplasma contamination [37].
Staining Parasites for Rosetting Assays
To visualize IEs within rosettes, prior to each assay, the culture
was stained with either 25 mg/ml ethidium bromide (Sigma) or
1:10,000 SyBr Green (Molecular Probes) for 5 minutes at 37uC.
The IEs where then washed twice with incomplete media (RPMI
1640 as above, but without human serum or Albumax II), and
resuspended at 1% haematocrit in Binding Medium (BM)
composed of RPMI-1640 (without bicarbonate) supplemented
with 10% human serum, 2 mM L-glutamine (Invitrogen), 25 mM
HEPES (Lonza), 20 mM glucose (Sigma) and 25 mg/mL genta-
micin sulphate (Lonza). The absence of bicarbonate allows pH to
remain stable in non-gassed conditions during the adhesion assays.
Assessment of Rosette Frequency (RF) in Static Assays
Rosette frequency (RF) was determined by viewing a wet
preparation of stained culture suspension (10 ml on a clean
microscope slide covered by a 22622 mm coverslip) using
simultaneous white light and fluorescence to visualize both
infected and uninfected erythrocytes (Leica DMLB2 microscope).
A rosette is defined as an IE that binds two or more uninfected
erythrocytes. The RF is the percentage of IEs forming rosettes out
of 200 IEs counted. In each independent static experiment, RF
was calculated in three separate wet preparations from each
sample, and a mean value determined from the triplicate counts.
Rosette Disruption Assays under Static Conditions
Rosette disruption assays were carried out with parasite cultures
of greater than 50% rosette frequency. Parasite cultures were pre-
stained with 25 mg/ml of ethidium bromide as described above.
Rabbit polyclonal antibodies (total purified IgG) against the NTS-
DBLa region of the ITvar09/R29var1 [25] and TM284var1 [24]
PfEMP1 variants were added to the corresponding IE suspension
to give a final concentration of 100, 10 and 1 mg/ml, and
incubated at 37uC for 30 minutes and compared to a ‘‘no
additive’’ negative control. Similarly, heparin and fucoidan
(Sigma) were added to give final concentrations of 100, 10 and
1 mg/ml (heparin) and 100 mg/ml (fucoidan), and incubated at
37uC for 30 minutes and compared to a ‘‘no additive’’ negative
control. Rosette frequency was assessed as above.
Rosette Disruption Assays under Flow
Flow assays were carried out using the ibidi flow system (ibidi,
Germany, http://ibidi.com/xtproducts/en/Instruments-
Accessories/Pump-Systems/ibidi-Pump-System). This consists of
a pump and fluidic unit used with a perfusion set (ibidi yellow/
green: Cat. No. #10964– length 50 cm, inner diameter 1.6 mm
with 10 ml reservoirs) and a m-slide I 0.8 (dimensions:
800 mm65 mm650 mm) constructed of optical quality polymer.
The flow rates tested gave a wall shear stress of 0.5, 0.75 and
1 dyn/cm2, which have been widely used to mimic wall shear
stresses in the microvasculature [33,38,39,40]. All observations
and measurements of rosetting under physiological shear stress
where conducted within the area of homogenous shear stress. For
m-slide I 0.8, this is at least 800 mm away from the channel walls,
however, as recommended by the manufacturer, all observations
are made down the central line of the slide, away from the 800 mm
Plasmodium falciparum Rosetting under Flow
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boundary from the channel wall (Application Note AN-11, www.
ibidi.de). The m-slide I chambers (ibidi, Germany) were blocked
overnight at 4uC with PBS/1% BSA. In the absence of this
blocking step, both IEs and non-IEs showed some non-specific
adhesion to the chamber wall. The following day, 3 ml of pre-
stained IE suspension at 5% parasitaemia and 1% Ht in BM
(pH 7.4)/10% pooled human serum was prepared. The suspen-
sion was added to the perfusion system and allowed to flow over
the m-slide I for 5 minutes at 0.5 dyn/cm2, before stopping the
flow and immediately capturing both bright-field and fluorescence
images from 10 consecutive fields (0.2 mm2 per field) with a 206
objective, using an EVOS FL digital inverted fluorescence
microscope (AMG). The flow was restarted at 5 dyn/cm2 for 2
minutes to disperse any cells that may have settled in the
reservoirs, before setting the flow rate to 0.75 dyn/cm2 and
repeating the procedure as above. After capturing images at
0.75 dyn/cm2, a further 2 minute dispersal step at 5 dyn/cm2was
carried out, and the above procedure repeated at 1 dyn/cm2. For
assessment of rosetting in the presence of rosette-disrupting agents,
the relevant amount of drug/antibody was added to the parasite
suspension 30 minutes prior to the assay, then the suspension was
flowed over the chamber slide at the shear stresses described
above. In each experiment, the ‘‘no antibody/drug’’ negative
control sample was tested first, followed by the samples containing
antibody/drug starting from the lowest concentration (1 mg/ml)
followed by 10 mg/ml then 100 mg/ml.
Quantification of Rosetting Under Flow
Using ImageJ software (http://rsb.info.nih.gov/ij/), each of the
10 images corresponding to 10 fields per sample were analysed,
and the total rosette area per field was measured. The composite
images (containing both bright-field and fluorescence information)
were opened in ImageJ, and as the EVOS FL software
automatically adds a scale bar to the composite image, this served
as a marker to calibrate the images for measurement. Using the
existing scale bar, it was determined that 2.56 pixels = 1 mm. With
the scale set, the images could then be prepared for analysis. In
preparation for measurement, the threshold settings were adjusted
to highlight the rosettes, in order to allow the margins of the cell
clusters to be identified more clearly. Briefly, the captured images
were processed using brightness and contrast, followed by
threshold to enhance the visualization of rosettes against the
background. Then, using the Analyze/Measurement settings,
rosettes were selected with the ‘wand’ tool, which highlights the
circumference of the selected rosette and calculates the area (mm2).
All of the measurements from each image were added and the
results expressed as total rosette area (mm2) from 10 fields.
Statistical Analysis and Graphing
Data were analysed and graphs prepared using GraphPad
Prism v5.0. (GraphPad Software Inc.) and JMP v10.0.2 (SAS
Institute Inc.). Mean rosetting values from at least three
independent experiments for each antibody/drug and shear stress
were compared by one-way ANOVA, with p,0.05 being taken as
statistically significant. The significant tests were analysed further
by Tukey’s post-hoc test, to compare individual antibody/drug
concentrations to the control. Finally, rosetting values were
converted to percentage of the ‘‘no additive’’ control value, to
allow direct comparison between data from static and flow assays.
In a small number of cases, the assumption of homogeneity of
variance was violated, however, repeating the ANOVA analysis
with Welch’s F test and Dunnett’s post-hoc test did not materially
alter the results.
Results
Large ‘‘Multi-rosettes’’ form under Flow Conditions
To determine the ability of IEs to form rosettes under shear
stresses similar to those experienced in the microvasculature in vivo,
two P. falciparum rosetting strains IT/R29 and TM284R+ were
examined using an ibidi perfusion system at 0.5, 0.75 and 1 dyn/
cm2. In each case, the rosette frequency (percentage of IEs binding
two or more uninfected erythrocytes) of the culture under static
conditions was assessed prior to the flow experiments. Under static
conditions, rosettes are usually small, isolated clusters of cells, with
one or two IE and 2–10 non-IE per rosette (Fig. 1A and C). In
contrast, under flow, many ‘‘multi-rosettes’’ are formed due to
individual rosettes sticking together into larger clumps (Fig. 1B and
D, white arrows). These large multi-rosettes behaved as single
‘objects’ within the flow (see Video S1). The experiments described
below focus on two well-characterized rosetting parasite strains
IT/R29 and TM284R+. However, several other rosetting P.
falciparum strains (IT/PAR+, TM180R+, Muz12R+ and HB3R+)
were also examined under flow, and in all cases, large ‘‘multi-
rosettes’’ formed under physiological flow conditions. Non-IEs and
non-rosetting P. falciparum cultures did not form rosettes or multi-
rosettes under flow.
Because of the presence of multi-rosettes comprising three-
dimensional clumps with many IEs buried within the clump, it was
not possible to count rosette frequency (percentage of IEs in
rosettes) in the flow assay, as is routinely done in the static assay.
Therefore, an alternative method of quantification of rosetting was
developed, using image analysis software (ImageJ). This software
allows for measurement of the area (mm2) of every cell cluster in a
field (0.2 mm2), including both individual rosettes and multi-
rosettes, as described in detail in the Methods section. Briefly, the
wand tool was used to highlight the circumference of the selected
rosette and calculate the area (mm2) (Fig. 1E). All of the rosette
area measurements from each image were then added to give the
total rosette area (mm2) from 10 fields at every shear stress and
condition examined below. In all experiments the multi-rosettes
contained IEs, and similar clusters of non-IEs were not seen.
Rosetting does not Vary Over the Range of Shear Stresses
from 0.5–1 dyn/cm2
We firstly investigated whether rosetting was affected by shear
stress between the range of 0.5 and 1 dyn/cm2. These values were
chosen because they have been widely used to approximate the
shear stress in post-capillary venules in previous studies of P.
falciparum IE cytoadherence to endothelial cells [33,38,39,40].
Using P. falciparum strain IT/R29, there was a trend towards
higher rosetting at higher shear stress, however, this was not
statistically significant (Fig. 2A, one-way ANOVA F(2,15) = 1.0,
p = 0.40, n= 6 experiments). Likewise, with parasite strain
TM284R+ there was no statistically significant effect of shear
stress in the range 0.5–1 dyn/cm2 on rosetting, although in this
case there was a trend towards reduced rosetting with increasing
shear stress (Fig. 2B, one-way ANOVA F(2,9) = 0.3, p = 0.72, n = 4
experiments).
Effects of Anti-rosetting Agents on IT/R29 Parasites under
Flow
Having confirmed that rosettes do persist under physiologically-
relevant shear stresses (Fig. 1), and can be quantified under flow
conditions (Fig. 2), we proceeded to test the effect of anti-rosetting
agents under flow. We previously showed that antibodies against
the NTS-DBLa region of the rosette-mediating PfEMP1 variant
ITvar09 (also known as R29var1) are able to significantly disrupt
Plasmodium falciparum Rosetting under Flow
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rosettes in the IT/R29 parasite strain under static conditions [25].
To determine if shear stress affects the rosette-disrupting ability of
these antibodies, we pre-incubated IT/R29 culture suspension
with varying concentrations of antibody (1, 10 and 100 mg/ml) for
30 minutes prior to measuring rosetting in a static assay and under
flow at 0.5, 0.75 and 1 dyn/cm2. In each case rosetting was
compared to a control culture with no added antibody. As
expected, all three concentrations of antibody gave significant
rosette disruption in the static assay (Fig. 3A, one-way ANOVA
F(3,8) = 78.3, p,0.0001). The same result was seen under flow,
with significant rosette disruption at all three antibody concentra-
tions at all three shear stresses (Fig. 3B, 0.5 dyn/cm2, one-way
ANOVA F(3,8) = 24.4, p= 0.0002; Fig. 3C, 0.75 dyn/cm2, one-
way ANOVA F(3,8) = 21.6, p= 0.0003 and Fig. 3D, 1.0 dyn/cm2,
one-way ANOVA F(3,8) = 12.7, p = 0.002). Because the data in
Figure 2 showed that there were no statistically significant
Figure 1. Rosetting in static and flow conditions. A) Parasite strain IT/R29 under static conditions. IEs at 5% parasitaemia and 1% haematocrit
were stained with 25 mgml ethidium bromide to visualize the parasite DNA, seen as bright white areas within IEs. Wet preparations were viewed
under dual brightfield/UV fluorescence (6100). The images were captured using a Q-imaging camera attached to an Olympus BX50 microscope. B)
Parasite strain IT/R29 under flow. 3 ml of parasite culture at 5% parasitaemia and 1% haematocrit was flowed over a m-slide I (ibidi, Germany) at
0.5 dyn/cm2 for 5 minutes. The flow was stopped and images captured immediately using an EVOS FL inverted fluorescence microscope (620). IEs
were stained with 1:10,000 dilution of SyBr Green prior to the assay to identify IEs within the rosettes clearly. White arrows indicate ‘‘multi-rosettes’’
seen under flow conditions. C) Parasite strain TM284R+ under static conditions, as described in A. D) Parasite strain TM284R+ under flow as described
in B. E) IT/R29 multi-rosette from a flow experiment at 0.5 dyn/cm2, demonstrating the use of ImageJ to draw the circumference and measure the
surface area of the selected multi-rosette and expressed as mm2.
doi:10.1371/journal.pone.0073999.g001
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differences between the different shear stresses, we also examined
the data after combining the experiments performed at 0.5, 0.75
and 1.0 dyn/cm2. As expected, significant rosette disruption at all
three antibody concentrations was seen (Fig. 3E, one-way
ANOVA F(3,32) = 45.1, p,0.0001). To determine if the extent
of rosette disruption in the flow assays differed from that in the
static assay, all data were converted into percentage of the ‘‘no
antibody’’ control, and the flow values at each antibody
concentration were compared to the static value (Fig. 3F–H). At
all three antibody concentrations, there were no statistically
significant differences between the rosetting values derived from
the flow assays compared to the static assay.
The same procedure was followed with a second, distinct
rosette-disrupting agent, by testing the effect of heparin on IT/
R29 rosetting at three concentrations (1, 10 and 100 mg/ml) under
static and flow conditions. In each case rosetting was compared to
a control culture with no added heparin. Under static conditions,
IT/R29 rosetting was significantly reduced at all three heparin
concentrations (Fig. 4A, one-way ANOVA F(3,8) = 81.1,
p,0.0001). Similar results were seen under flow, with significant
disruption of rosetting at all three shear stresses (Fig. 4B, 0.5 dyn/
cm2 one-way ANOVA F(3,8) = 8.1, p = 0.0082; Fig. 4C,
0.75 dyn/cm2 one-way ANOVA F(3,8) = 5.3, p= 0.03 and
Fig. 4D, 1.0 dyn/cm2 one-way ANOVA F(3,8) = 6.0, p = 0.02).
However, the high level of variation between experiments under
flow meant that not all individual heparin concentrations were
statistically significant (Fig. 4C, 10 and 1 mg/ml and Fig. 4D,
1 mg/ml are not statistically different to the control value by
Tukey’s post test). When the data from experiments at all three
shear stresses were combined, all concentrations of heparin gave
significantly reduced rosetting (Fig. 4E, one-way ANOVA
F(3,32) = 17.8, p=,0.0001). As above, conversion of all data to
a percentage of the ‘‘no additive’’ control value was carried out to
allow direct comparison between results from the static and flow
assays. At all three heparin concentrations, there were no
statistically significant differences between the rosetting values
derived from the flow assays compared to the static assay (Fig. 4F–
H).
IT/R29 was also tested in static and flow assays with 100 mg/ml
fucoidan, which completely disrupted all rosettes in every
experiment. Representative images from this, and the above
rosetting flow experiments are shown in Fig. S1.
Effects of Anti-rosetting Agents on TM284R+ Parasites
under Flow
Further experiments were carried out with a different P.
falciparum rosetting strain TM284R+, whose rosettes are more
resistant to rosette-disrupting agents than IT/R29 [16]. Antibodies
to the NTS-DBLa region of the rosette-mediating PfEMP1 variant
TM284var1 were used [24], and tested in static assays and under
three different shear stresses as above. In the static assay,
statistically significant rosette disruption was seen at 100 mg/ml
of antibody only (Fig. 5A, one-way ANOVA F(3,12) = 4.5,
p = 0.02). Similar trends of rosette disruption at 100 mg/ml of
antibody were seen in the flow assay at all three shear stresses (Fig.
S2 A–C). However, due to the high level of variation in the control
values between experiments, these differences were not statistically
significant (Fig. S2A, 0.5 dyn/cm2, one-way ANOVA
F(3,12) = 2.1, p = 0.15; Fig. S2B, 0.75 dyn/cm2, one-way ANOVA
F(3,12) = 2.3, p = 0.12; Fig. S2C, 1.0 dyn/cm2, one-way ANOVA
F(3,12) = 2.1, p = 0.16). When the data from experiments at all
three shear stresses were combined, 100 mg/ml of antibody gave
significantly reduced rosetting compared to the control (Fig. 5B,
one-way ANOVA F(3,32) = 7.1, p = 0.0005). When data were
converted to a percentage of the ‘‘no antibody’’ control as above,
there were no statistically significant differences between rosetting
values derived from the flow assays compared to the static assay
(Fig. 5 C–E).
TM284R+ rosettes have been shown previously to be resistant
to heparin in static assays, but are partially disrupted by fucoidan
at 100 mg/ml [16]. We therefore tested the ability of 100 mg/ml
fucoidan to disrupt TM284R+ rosettes in static and flow
conditions. As expected, in the static assay the TM284R+ rosettes
Figure 2. The effect of shear stress (0.5–1 dyn/cm2) on
rosetting. Parasite cultures were subjected to shear stresses of 0.5,
0.75 or 1.0 dyn/cm2 in an ibidi flow system as described for Figure 1,
and images from 10 fields (206 objective) were captured by
fluorescence microscopy. The total rosette area (mm2) from 10 fields
at each shear stress was determined using ImageJ software. A) Parasite
strain IT/R29 was tested in six independent experiments, and the mean
of the total rosette area from each experiment is shown. Error bars
indicate standard error of the mean. B) Parasite strain TM284R+ was
tested in four independent experiments, and the mean of the total
rosette area from each experiment is shown. Error bars indicate
standard error of the mean. There were no statistically significant
differences between the mean rosette areas at the three different shear
stresses for either parasite strain by one-way ANOVA.
doi:10.1371/journal.pone.0073999.g002
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Figure 3. The effect of PfEMP1 antibodies on rosetting in static and flow assays with parasite strain IT/R29. Antibodies to the NTSDBLa
region of the PfEMP1 variant ITvar09/R29var1 were added to IT/R29 parasite culture suspension at a final concentration of 100, 10 and 1 mg/ml of
antibody and incubated for 30 mins before assessment of rosetting. The control was a culture suspension with no added antibody. A) Static assay:
the percentage in IEs in rosettes (rosette frequency) was assessed by fluorescence microscopy of ethidium bromide-stained wet preparations. B–D)
Flow assays: total rosette area (mm2) from 10 fields (206 objective) was determined after 5 minutes under flow at each shear stress using ImageJ
software. E) Flow assays: experiments at all shear stresses combined. F–H) To allow direct comparison of the results from static and flow assays, the
rosetting values from each experiment were converted to a percentage of the ‘‘no additive’’ control value. F) IT/R29 parasites with 100 mg/ml PfEMP1
antibody. G) IT/R29 parasites with 10 mg/ml PfEMP1 antibody. H) IT/R29 parasites with 1 mg/ml PfEMP1 antibody. Mean and standard error from three
independent experiments (A–D and F–H) or nine experiments (E) are shown. Mean values that are statistically significantly different from the control
value (A–E) or the static value (F–H) by one-way ANOVA with Tukey’s post test are shown by asterisks, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0073999.g003
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were significantly disrupted by 100 mg/ml fucoidan (Fig. 6A, two-
tailed paired t test, p = 0.0049). A similar pattern of disruption was
seen under flow (Fig. S3 A–C), although this only reached
statistical significance when experiments from all three shear
stresses were combined (Fig. 6B, two-tailed paired t test, p = 0.04).
When data at each shear stress were converted to a percentage of
the ‘‘no antibody’’ control as above, there were no statistically
Figure 4. The effect of heparin on rosetting in static and flow assays with parasite strain IT/R29. Heparin was added to IT/R29 parasite
culture suspension at a final concentration of 100, 10 and 1 mg/ml and incubated for 30 mins before assessment of rosetting. The control was a
culture suspension with no added heparin. A) Static assay: the percentage in IEs in rosettes (rosette frequency) was assessed by fluorescence
microscopy of ethidium bromide-stained wet preparations. B–D) Flow assays: total rosette area (mm2) from 10 fields (206objective) was determined
after 5 minutes under flow at each shear stress using ImageJ software. E) Flow assays: experiments at all shear stresses combined. F–H) To allow direct
comparison of the results from static and flow assays, the rosetting values from each experiment were converted to a percentage of the ‘‘no additive’’
control value. F) IT/R29 parasites with 100 mg/ml heparin. G) IT/R29 parasites with 10 mg/ml heparin. H) IT/R29 parasites with 1 mg/ml heparin. Mean
and standard error from three independent experiments (A–D and F–H) or nine experiments (E) are shown. Mean values that are statistically
significantly different from the control value (A–E) or the static value (F–H) by one- way ANOVA with Tukey’s post test are shown by asterisks,
*p,0.05, ***p,0.001.
doi:10.1371/journal.pone.0073999.g004
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significant differences between rosetting values derived from the
flow assays compared to the static assay (Fig. 6C).
The effect of 100 mg/ml heparin on TM284R+ was also tested
in a single experiment, but as expected from previous work, high
levels of rosetting were seen in all samples with no evidence of any
rosette disruption. This was not formally quantified, however,
representative images from this, and the above rosetting flow
experiments are shown in Fig. S4.
Discussion
This study developed a new P. falciparum rosetting flow assay and
investigated the effect of anti-rosetting agents under physiological
shear stresses compared to static assays. Current screening
methods for anti-rosetting agents use static wet preparations and
the IEs are not subjected to shear stresses similar to those that
would be experienced in vivo. We hypothesized that the effect of
rosette-disrupting agents might be enhanced when exposed to
physiologically relevant shear stresses similar to those found within
human capillaries and post-capillary venules (0.5–1.0 dyn/cm2),
because the shear stresses might contribute to the disruption of the
cell clusters.
In order to test our hypothesis, we established a new rosetting
flow assay using an ibidi flow system and ImageJ software to
quantify rosetting under different shear stresses. The ibidi
perfusion system allows for the control of shear stress in a closed
system, while using a relatively small volume (3 ml) of culture
suspension. The ibidi m-slide I chambers allow for the visualisation
of rosettes under flow by digital inverted microscopy and the
capturing of images for later analysis. The system allows for
capturing of images of rosettes directly from flow, without the need
for intermediate steps.
Figure 5. The effect of PfEMP1 antibodies on rosetting in static and flow assays with parasite strain TM284R+. Antibodies to the
NTSDBLa region of the PfEMP1 variant TM284var1 were added to TM284R+ parasite culture suspension at a final concentration of 100, 10 and 1 mg/
ml of antibodies and incubated for 30 mins before assessment of rosetting. The control was a culture suspension with no added antibody. A) Static
assay: the percentage in IEs in rosettes (rosette frequency) was assessed by fluorescence microscopy of ethidium bromide-stained wet preparations.
B) Flow assay using combined data from experiments at 0.5, 0.75 and 1.0 dyn/cm2. The total rosette area (mm2) from 10 fields (206objective) was
determined after 5 minutes under flow at each shear stress using ImageJ software. C–E) To allow direct comparison of the results from static and flow
assays, the rosetting values from each experiment were converted to a percentage of the ‘‘no additive’’ control value. C) TM284R+ parasites with
100 mg/ml PfEMP1 antibody. D) TM284R+ parasites with 10 mg/ml PfEMP1 antibody. E) TM284R+ parasites with 1 mg/ml PfEMP1 antibody. Mean and
standard error from four independent experiments (A and C–E), or twelve experiments (B) are shown. Mean values that are statistically significantly
different from the control value (A–B) or the static value (C–E) by one-way ANOVA with Tukey’s post test are shown by asterisks, *p,0.05.
doi:10.1371/journal.pone.0073999.g005
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Using this system, we found that, in agreement with previous
work [5,30,31,32], rosettes do exist under physiologically relevant
shear stresses (Figs. 1 and 2). Once subjected to flow, classical
rosettes comprising one IE plus two or more non-IEs (Fig. 1 A and
C) often combine with other rosettes and non-IEs to form larger
clusters of ‘‘multi-rosettes’’ (Fig. 1 B and D). These behave within
the flow as a single object and have various sizes and
conformations (Video S1). Large multi-rosettes (sometimes called
‘‘giant rosettes’’) have occasionally been reported from static assays
[41]. Our experiments show that multi-rosettes occur commonly
under the continuous flow conditions used here.
Using the new flow assay, we tested rosette-disrupting
PfEMP1antibodies and sulphated glycoconjugate drugs on two
P. falciparum rosetting strains (IT/R29 and TM284R+), and
compared the results from static and flow assays. In all cases we
found very similar patterns of rosette disruption under flow
compared to static conditions (Figs. 3–6). There was no evidence
to support any statistically significant difference between the results
of the flow and static assays at the antibody and drug
concentrations tested. Therefore under the conditions used here,
the data do not support our hypothesis, but instead suggest that
physiologically relevant shear stresses neither enhance nor reduce
the activity of rosette-disrupting agents such as PfEMP1 antibodies
or sulphated glycoconjugate compounds. Whether other rosette-
disrupting interventions, such as soluble recombinant rosetting
receptors including CR1 [10,42] and ABO blood group sugars
[9,43] will behave similarly under flow will require further
investigation.
The new rosetting flow assay described here allows for the
assessment of rosetting under shear stresses similar to those found
in vivo. However, the assay does have some limitations and
disadvantages. The flow assay is time-consuming, requires
specialized equipment, and shows more intrinsic variation from
one experiment to the next than the static assay. The most time-
consuming part of the procedure is the image analysis, which took
several hours per sample, compared to just a few minutes per
sample to assess rosetting in the static assay. However, the image
analysis could potentially be automated [44], thus stream-lining
the process and facilitating more repeated experiments to
overcome the innate variation between experiments. The exper-
imental set-up could also be adjusted for future work. In the set of
experiments reported here, the rosette-disrupting agents were
added prior to addition of the culture into the perfusion system. It
would also be possible to add the agents to the parasite culture
suspension once it is circulating in the perfusion system to try to
make the assay more ‘‘life-like’’. However, in vivo, rosettes do not
circulate freely in the peripheral blood, but accumulations of IE
and non-IE are seen in post-capillary venules as part of the
sequestration process [5,45,46]. Rosetting IE may bind directly to
the endothelium [47] or may bind to sequestered non-rosetting IE
that are adherent to blood vessel walls. A more realistic rosetting
assay might involve allowing rosettes to form on endothelial cells
or on monolayers of IE bound to a microscope slide. In addition,
further modifications could be carried out in an attempt to mimic
in vivo conditions more closely, such as carrying out experiments
using whole blood, which would include leucocytes, platelets and
higher plasma concentrations compared to the existing assay.
Despite the time-consuming nature of the image analysis in the
new flow assay, it does have some advantages compared to
methods previously used to assess rosetting under shear stresses,
including the plate-cone viscometer [30,31] and LORCA [32].
These assays, whilst subjecting rosettes to shear stress, ultimately
calculate rosette frequency from a standard wet preparation. In
other words, after applying the shear stress, the culture suspension
is removed from the device and then a wet preparation is made
and viewed by microscopy. This necessitates a time delay in which
rosettes could reform or fall apart, and also necessitates the passing
of the cells through a pipette tip, which can apply an inconsistent
and poorly defined shear stress to the suspension. The use of a
closed perfusion system allows for visualization and data capture of
rosettes directly from flow.
Conclusions
In summary, the experiments shown here confirm that P.
falciparum rosettes exist under physiologically relevant shear
stresses, and describe a new rosetting flow assay that may be
useful for researchers interested in malaria host-parasite interac-
tions. There were no statistically significant differences in the
rosette-disrupting effects of PfEMP1 antibodies and sulphated
glycoconjugates under static and flow conditions. These results
increase confidence that the widely-used, quick and simple static
rosetting assay is a good predictor of results obtained under
physiological shear forces. Therefore static assays are likely to
Figure 6. The effect of fucoidan on rosetting in static and flow assays with parasite strain TM284R+. Fucoidan was added to TM284R+
parasite culture suspension at a final concentration of 100 mg/ml and incubated for 30 mins before assessment of rosetting. The control was a culture
suspension with no added fucoidan. A) Static assay: the percentage in IEs in rosettes was assessed by fluorescence microscopy of ethidium bromide-
stained wet preparations. B) Flow assay using combined data from experiments at 0.5, 0.75 and 1.0 dyn/cm2. The total rosette area (mm2) from 10
fields (206objective) was determined after 5 minutes under flow at each shear stress using ImageJ software. C) To allow direct comparison of the
results from static and flow assays, the rosetting values from each experiment were converted to a percentage of the ‘‘no additive’’ control value.
Mean and standard error from three independent experiments (A and C) or nine experiments (B) are shown. Mean values that are statistically
significantly different from the control value (A–B) or the static value (C) by a two-tailed paired t test are shown by asterisks, *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0073999.g006
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continue to be used for the majority of rosetting experiments and
screening assays, while the flow assay may be useful for more
detailed analysis of potential rosette-disrupting interventions.
Supporting Information
Figure S1 Effect of anti-rosetting agents on IT/R29
rosetting under flow. Representative images are shown for
each rosetting flow experiment.
(TIFF)
Figure S2 The effect of PfEMP1 antibodies on rosetting
in flow assays with parasite strain TM284R+. Antibodies
to the NTS-DBLa region of the PfEMP1 variant TM284var1
were added to TM284R+ parasite culture suspension at a final
concentration of 100, 10 and 1 mg/ml of antibody and incubated
for 30 mins before assessment of rosetting at A) 0.5 dyn/cm2 B)
0.75 dyn/cm2 and C) 1.0 dyn/cm2. The control was a culture
suspension with no added antibody. The total rosette area (mm2)
from 10 fields (206 objective) was determined after 5 minutes
under flow at each shear stress using ImageJ software. Mean and
standard error from four independent experiments at each shear
stress are shown. No statistically significant differences were found
by one-way ANOVA. The static assay data and the pooled flow
data from this experiment are shown in Figure 5 of the main
manuscript.
(TIFF)
Figure S3 The effect of fucoidan on rosetting in flow
assays with parasite strain TM284R+. 100 mg/ml of
fucoidan was added to TM284R+ parasite culture suspension
and incubated for 30 mins before assessment of rosetting at A)
0.5 dyn/cm2 B) 0.75 dyn/cm2 and C) 1.0 dyn/cm2. The control
was a culture suspension with no added fucoidan. The total rosette
area (mm2) from 10 fields (206 objective) was determined after 5
minutes under flow at each shear stress using ImageJ software.
Mean and standard error from three independent experiments at
each shear stress are shown. No statistically significant differences
were found by one-way ANOVA. The static assay data and the
pooled flow data from this experiment are shown in Figure 6 of the
main manuscript.
(TIFF)
Figure S4 Effect of anti-rosetting agents on TM284R+
rosetting under flow. Representative images are shown for
each rosetting flow experiment.
(TIF)
Video S1 The P. falciparum rosetting strain IT/PAR+
was added to the perfusion system at 5% parasitemia
and 1% haematocrit and subjected to a shear stress
0.5 dyn/cm2. Video was captured of the cells in flow (620
objective) using a Leica 6000B inverted microscope equipped with
DFC360FX camera recording at 30 frames per second. The video
clip shows IT/PAR+ ‘‘multi-rosettes’’ under flow and how they
exist as single objects, and further demonstrates the various sizes
and conformations observed under flow conditions.
(MOV)
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